Compare Enzyme (MLN) vs Orchid (OXT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Orchid — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Orchid trades at Rp164.34 (market cap Rp190,2M, Rp47,84M 24h volume). The key difference: Orchid is the larger of the two by market cap, and Enzyme's circulating supply is 3,3M MLN versus 997,2M OXT for Orchid. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Orchid for 42 Days on average.
| MLN | OXT | |
|---|---|---|
Market Cap | Rp134,13M | Rp190,2M |
Volume (24h) | Rp104,56M | Rp47,84M |
Circulating Supply | 3,3M MLN | 997,2M OXT |
Typical Hold Time | 28 Days | 42 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Orchid (OXT) shows modest market presence with a market cap of Rp190.2M and circulating supply of 997.2 million tokens. The asset demonstrates relatively low volatility with an average hold time of 42 days, suggesting stable holder behavior. Recent trading patterns indicate limited price discovery activity, with the token maintaining a narrow trading range. No major protocol updates or ecosystem developments have been reported recently, keeping the project in a consolidation phase.
Overall outlook remains neutral with limited near-term catalysts. Key opportunities include potential network adoption growth and protocol upgrades, while major risks involve low liquidity, regulatory uncertainty in the VPN/privacy token space, and limited trading volume. Investors should monitor on-chain activity and exchange listings for directional cues.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Orchid
Orchid describes itself as the world’s first incentivized, peer-to-peer privacy network. Its aim is to overcome internet freedom limitations by using cryptocurrency payments to allow anyone to purchase bandwidth from any participating provider. This is done using so-called probabilistic nanopayments, which occur using OXT, an ERC-20 standard token on Ethereum.
Read more on OXT →
